Company intelligence / Profile preview

SOL Group

Ownership: Private
Development stage: Other

Overview

SOL Group and subsidiaries like Diatheva and Personal Genomics offer certified diagnostic systems, reagents, molecular kits, and services for clinical diagnostics, translational medicine, and precision genomics. The group's diagnostics and bioproduction activities are commercial and actively serving hospital and research markets.

Therapeutic areas: Women's HealthInfectious DiseasesRare DiseasesOtherHematologyOncology
Modalities: Monoclonal antibodyRecombinant proteinMolecular kitDiagnostic kitBiologic
Industry: Molecular Diagnostics

Partnerships

Tor Vergata University of RomeVarious public and private diagnostics and hospital labs

Beyond the preview

Go deeper on SOL Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOL Group.